PTP
ABBV icon

Platform Technology Partners’s AbbVie ABBV Stock Holding History

Platform Technology Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Sell
10,636
-208
-2% -$44.8K 0.44% 58
2026
Q1 		$2.36M Buy
10,844
+700
+7% +$155K 0.45% 52
2025
Q4 		$2.32M Buy
10,144
+118
+1% +$26.9K 0.49% 48
2025
Q3 		$2.32M Sell
10,026
-241
-2% -$49.1K 0.56% 43
2025
Q2 		$1.91M Buy
10,267
+208
+2% +$38.7K 0.5% 53
2025
Q1 		$2.11M Buy
10,059
+854
+9% +$166K 0.61% 44
2024
Q4 		$1.64M Sell
9,205
-964
-9% -$177K 0.5% 57
2024
Q3 		$2.01M Sell
10,169
-280
-3% -$52.3K 0.63% 43
2024
Q2 		$1.79M Buy
+10,449
New +$1.73M 0.62% 46
2023
Q4 		$1.66M Sell
9,593
-233
-2% -$34K 0.65% 45
2023
Q3 		$1.46M Buy
9,826
+988
+11% +$145K 0.69% 39
2023
Q2 		$1.2M Sell
8,838
-98
-1% -$14.4K 0.56% 53
2023
Q1 		$1.42M Sell
8,936
-749
-8% -$115K 0.7% 41
2022
Q4 		$1.57M Sell
9,685
-121
-1% -$18.6K 0.81% 35
2022
Q3 		$1.32M Buy
9,806
+441
+5% +$63.3K 0.75% 36
2022
Q2 		$1.43M Sell
9,365
-928
-9% -$142K 0.78% 37
2022
Q1 		$1.67M Buy
10,293
+234
+2% +$34K 0.8% 31
2021
Q4 		$1.36M Buy
10,059
+323
+3% +$38.2K 0.6% 38
2021
Q3 		$1.05M Sell
9,736
-2,789
-22% -$319K 0.48% 53
2021
Q2 		$1.41M Buy
+12,525
New +$1.41M 0.58% 43
2020
Q4 		$1.33M Buy
12,418
+913
+8% +$87.7K 0.65% 37
2020
Q3 		$1.01M Buy
11,505
+8
+0.1% +$753 0.62% 37
2020
Q2 		$1.13M Buy
11,497
+1,900
+20% +$167K 0.79% 28
2020
Q1 		$731K Buy
9,597
+2,850
+42% +$243K 0.67% 38
2019
Q4 		$597K Buy
+6,747
New +$560K 0.45% 59

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Platform Technology Partners's ABBV Position: Q2 2026 in Review

Platform Technology Partners reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $44.8K and leaving 10,636 shares worth $2.68M. The position accounts for 0.44% of the portfolio, ranked #58.

Platform Technology Partners first reported a position in ABBV in Q4 2019 and has held it in 25 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Platform Technology Partners held 10,636 shares of AbbVie worth $2.68M as of Q2 2026.
  • Platform Technology Partners sold 208 AbbVie shares in Q2 2026, an estimated $44.8K.
  • AbbVie made up 0.44% of Platform Technology Partners's portfolio in Q2 2026, its #58 holding.
  • Platform Technology Partners first reported a position in AbbVie in Q4 2019 and has held it in 25 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.